Indeed, numerous studies have reported that the overexpression of CSF-1 and CCL2 is correlated with poor prognosis in numerous human cancers, including breast, ovarian, endometrial, prostate, hepatocellular, and colorectal cancer, etc. [15,48]. This evidence concerns the gene CSF1 and cancer.